Researchers
Discover all researchers in life sciences
Loading researchers...
Discover all researchers in life sciences
Researcher at Research Department
Ask questions about Keng Yoon Yeong's research, publications, and ongoing work
Developed novel benzimidazole derivatives and evaluated their potential as cholinesterase inhibitors, demonstrating promising results for Alzheimer's disease treatment.
Synthesized and evaluated benzimidazole derivatives for their sirtuin inhibitory activity, exploring their potential in anticancer therapy.
Conducted a patent review on benzimidazoles, highlighting the current developments and applications of benzimidazole-based compounds in drug discovery.
Reviewed the current developments of benzoxazoles in drug discovery, providing insights into their therapeutic potential.
Investigated the role of sirtuins in neurodegenerative diseases, providing a drug discovery perspective.
Synthesized and evaluated novel benzimidazole derivatives as sirtuin inhibitors with antitumor activities.
Investigated the use of scopolamine, a toxin-induced experimental model, for research in Alzheimer's disease.
Dr. Keng Yoon Yeong is a medicinal chemist specializing in drug discovery, particularly in the design and synthesis of novel compounds for treating neurodegenerative diseases and cancer. His research focuses on cholinesterase and sirtuin inhibitors, with a strong emphasis on benzimidazole derivatives and their therapeutic potential.
Researchers with overlapping expertise and complementary work
Finding similar researchers...